Skip to main content
MEHA
NASDAQ Life Sciences

Functional Brands Amends CFO Appointment Disclosure, Reveals Related-Party Contract with New CFO's Firm

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
8
Price
$0.116
Mkt Cap
$4.975M
52W Low
$0.057
52W High
$8
Market data snapshot near publication time

summarizeSummary

Functional Brands Inc. filed an amended 8-K to disclose a previously unannounced related-party services agreement with an entity owned by its newly appointed Chief Financial Officer.


check_boxKey Events

  • Related-Party Contract Disclosed

    The company amended its prior 8-K to disclose a Services Agreement with Atlas Bookkeeping, LLC, an entity owned by the newly appointed CFO, David R. Wells. This agreement was not disclosed in the original filing regarding his appointment.

  • Significant Contract Value

    Atlas Bookkeeping, LLC has been providing services since November 2025. The monthly fee was increased from $13,000 to $18,000 effective April 15, 2026, with total payments to date of approximately $89,833.

  • Governance Concerns Raised

    The initial omission of this related-party transaction, coupled with the new CFO's ownership of the service provider, raises questions about corporate governance and potential conflicts of interest, particularly for a company facing significant financial and operational challenges.

  • CFO Appointment Context

    This disclosure follows the appointment of David R. Wells as CFO, Principal Financial Officer, Principal Accounting Officer, and a Board member, effective May 18, 2026, succeeding Tariq Rahim who transitioned to a non-executive role.


auto_awesomeAnalysis

This amendment reveals a significant related-party transaction that was omitted from the original filing announcing the new CFO's appointment. The company's newly appointed CFO, David R. Wells, owns Atlas Bookkeeping, LLC, which has been providing financial and administrative services to Functional Brands since November 2025. The monthly fee for these services was recently increased to $18,000, totaling approximately $89,833 paid to date. This arrangement, representing a substantial annual cost relative to the company's small market capitalization, raises governance concerns, especially given the company's ongoing financial challenges, recent large acquisition, and efforts to avoid delisting.

At the time of this filing, MEHA was trading at $0.12 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5M. The 52-week trading range was $0.06 to $8.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed MEHA - Latest Insights

MEHA
May 22, 2026, 10:14 AM EDT
Filing Type: 8-K/A
Importance Score:
8
MEHA
May 22, 2026, 9:06 AM EDT
Filing Type: 8-K
Importance Score:
10
MEHA
May 22, 2026, 9:00 AM EDT
Source: TMX Newsfile
Importance Score:
10
MEHA
May 21, 2026, 5:15 PM EDT
Filing Type: DEFA14A
Importance Score:
9
MEHA
May 20, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
MEHA
May 19, 2026, 5:00 PM EDT
Filing Type: DEFA14A
Importance Score:
9
MEHA
May 15, 2026, 5:11 PM EDT
Source: Wiseek News
Importance Score:
9
MEHA
May 15, 2026, 5:03 PM EDT
Filing Type: 10-Q
Importance Score:
10
MEHA
May 11, 2026, 5:45 PM EDT
Filing Type: 8-K
Importance Score:
8
MEHA
May 11, 2026, 8:10 AM EDT
Filing Type: 8-K
Importance Score:
10